TIS 0.00% 0.0¢ tissue therapies limited

CE Mark, page-9

  1. 2,026 Posts.
    lightbulb Created with Sketch. 47
    As I understand it the EMA asked for a delay in their process due to workload and Christmas but they also brought forward some questions that would normally answered after approval. If they weren't fairly happy with what the answers that TIS had provided in the past and that they were going to be ready to approve Vitrogrow after this round then surely they wouldn't have asked for the post approval questions as well?
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.